Influence of route of administration and lipidation of apolipoprotein A-I peptide on pharmacokinetics and cholesterol mobilization

Influence of route of administration and lipidation of apolipoprotein A-I peptide on pharmacokinetics and cholesterol mobilization

apoA-I, apoA-I mimetic peptides, and their lipid complexes or reconstituted high-density lipoprotein (HDL) have been studied as treatments for various pathologies. However, consensus is lacking about the best method for administration, by intravenous (IV) or intraperitoneal (IP) routes, and formulat...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Jie Tang, Dan Li, Lindsey Drake, Wenmin Yuan, Sara Deschaine, Emily E. Morin, Rose Ackermann, Karl Olsen, David E. Smith, Anna Schwendeman
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	Elsevier 2017-01-01
Reeks:	Journal of Lipid Research
Onderwerpen:	HDL lipoproteins/metabolism apolipoprotein A-I mimetic peptides lipoprotein remodeling PK-PD modeling
Online toegang:	http://www.sciencedirect.com/science/article/pii/S0022227520314413

Gelijkaardige items

Efficacy and Safety of High-Density Lipoprotein/Apolipoprotein A1 Replacement Therapy in Humans and Mice With Atherosclerosis: A Systematic Review and Meta-Analysis
door: Ayiguli Abudukeremu, et al.
Gepubliceerd in: (2021-08-01)

A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids
door: Mohamad Navab, et al.
Gepubliceerd in: (2009-08-01)

Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide <span style="font-variant: small-caps">d</span>-[113–122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice
door: Andrea Rivas-Urbina, et al.
Gepubliceerd in: (2020-05-01)

D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet
door: Georgette M. Buga, et al.
Gepubliceerd in: (2008-01-01)

Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research
door: Karin Kornmueller, et al.
Gepubliceerd in: (2019-08-01)

Surface pressure-dependent conformation change of apolipoprotein-derived amphipathic α-helices
door: Matthew A. Mitsche, et al.
Gepubliceerd in: (2013-06-01)

Characterization and quantification of serum lipoprotein subfractions by capillary isotachophoresis: relationships with lipid, apolipoprotein, and lipoprotein levels
door: Alexandra Schlenck, et al.
Gepubliceerd in: (1999-11-01)

Three arginine residues in apolipoprotein A-I are critical for activation of lecithin:cholesterol acyltransferase
door: Stein Roosbeek, et al.
Gepubliceerd in: (2001-01-01)

Apolipoprotein E3-mediated cellular uptake of reconstituted high-density lipoprotein bearing core 3, 10, or 17 nm hydrophobic gold nanoparticles
door: Chuang ST, et al.
Gepubliceerd in: (2017-11-01)

Reconfiguring Nature’s Cholesterol Accepting Lipoproteins as Nanoparticle Platforms for Transport and Delivery of Therapeutic and Imaging Agents
door: Skylar T. Chuang, et al.
Gepubliceerd in: (2020-05-01)

High-density Lipoproteins and Apolipoprotein A-I: Potential New Players in the Prevention and Treatment of Lung Disease
door: Elizabeth M. Gordon, et al.
Gepubliceerd in: (2016-09-01)

Apolipoprotein E content of VLDL limits LPL-mediated triglyceride hydrolysis
door: Brynne E. Whitacre, et al.
Gepubliceerd in: (2022-01-01)

A Current Update on the Role of HDL-Based Nanomedicine in Targeting Macrophages in Cardiovascular Disease
door: Alankrita Rani, et al.
Gepubliceerd in: (2023-05-01)

Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma
door: David Meriwether, et al.
Gepubliceerd in: (2011-10-01)

A role of apolipoprotein D in triglyceride metabolism[S]
door: German Perdomo, et al.
Gepubliceerd in: (2010-06-01)

Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese
door: Kuo-Liong Chien, et al.
Gepubliceerd in: (2007-11-01)

Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism
door: Margaret E. Brousseau, et al.
Gepubliceerd in: (2009-07-01)

Apolipoprotein B/A1 Ratio as a Diagnostic Alternative to Triglycerides and HDL-Cholesterol for the Prediction of Metabolic Syndrome among Hypertensives in Kazakhstan
door: Alma Nurtazina, et al.
Gepubliceerd in: (2020-07-01)

Peptide model of a highly conserved, N-terminal domain of apolipoprotein E is able to modulate lipoprotein binding to a member of the class A scavenger receptor family
door: Samuel R. Dominguez, et al.
Gepubliceerd in: (1999-04-01)

Strategies for consistent and automated quantification of HDL proteome using data-independent acquisition
door: Douglas Ricardo Souza Junior, et al.
Gepubliceerd in: (2023-07-01)

Plasma apolipoprotein O level increased in the patients with acute coronary syndrome
door: Bi-lian Yu, et al.
Gepubliceerd in: (2012-09-01)

HDL in Endocrine Carcinomas: Biomarker, Drug Carrier, and Potential Therapeutic
door: Emily E. Morin, et al.
Gepubliceerd in: (2018-11-01)

Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally[S]
door: Mohamad Navab, et al.
Gepubliceerd in: (2011-06-01)

Identification of genetic drivers of plasma lipoprotein size in the Diversity Outbred mouse population
door: Tara R. Price, et al.
Gepubliceerd in: (2023-12-01)

Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins
door: Shucun Qin, et al.
Gepubliceerd in: (2000-02-01)

The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease
door: Dustin Chernick, et al.
Gepubliceerd in: (2020-09-01)

The Differential Effects of HDL Subpopulations on Lipoprotein Lipase (LPL)-Mediated VLDL Catabolism
door: Ewa Wieczorek, et al.
Gepubliceerd in: (2021-12-01)

A Systematic Review of Apolipoprotein A-I Mimetic Peptides for Atherosclerosis Therapy via Activation of Reverse Cholesterol Transport Pathway
door: Aiman Asaduddin, et al.
Gepubliceerd in: (2022-11-01)

HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity
door: Mark S. Borja, et al.
Gepubliceerd in: (2015-10-01)

The ratio of low-density lipoprotein cholesterol to apolipoprotein-B as a marker of low-density lipoprotein particle size
door: A. M. Kaneva, et al.
Gepubliceerd in: (2018-06-01)

Apolipoprotein A-I charge and conformation regulate the clearance of reconstituted high density lipoprotein in vivo
door: Sylvie Braschi, et al.
Gepubliceerd in: (1999-03-01)

Structure dynamics of ApoA-I amyloidogenic variants in small HDL increase their ability to mediate cholesterol efflux
door: Oktawia Nilsson, et al.
Gepubliceerd in: (2021-01-01)

Establishing Apolipoprotein-B and non-high-density-lipoprotein-C goals in Indian population: A Cross-sectional study
door: Parul Berry, et al.
Gepubliceerd in: (2024-05-01)

Cholesterol: Good or bad?
door: Larbi ALAOUI
Gepubliceerd in: (2019-09-01)

Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits
door: Brian J. Van Lenten, et al.
Gepubliceerd in: (2007-11-01)

Association of polymorphism apolipoprotein A1 with the lipid profile serum
door: E. V. Schakhtschneider, et al.
Gepubliceerd in: (2010-12-01)

Cholesterol–sphingomyelin interaction in membrane and apolipoprotein-mediated cellular cholesterol efflux
door: Jin-ichi Ito, et al.
Gepubliceerd in: (2000-06-01)

Effect of apolipoprotein A-IV genotype and dietary fat on cholesterol absorption in humans
door: Richard B. Weinberg, et al.
Gepubliceerd in: (2000-12-01)

Apolipoprotein A-I, A-II, and VLDL-B-100 metabolism in men
door: Sophie Desroches, et al.
Gepubliceerd in: (2004-12-01)

The kringle IV type 2 domain variant 4925G>A causes the elusive association signal of the LPA pentanucleotide repeat
door: Rebecca Grüneis, et al.
Gepubliceerd in: (2022-12-01)